149 related articles for article (PubMed ID: 18698162)
1. Vessel normalization by VEGF inhibition. A complex story.
Claes A; Leenders W
Cancer Biol Ther; 2008 Jul; 7(7):1014-6. PubMed ID: 18698162
[No Abstract] [Full Text] [Related]
2. Contrast enhanced MRI and intravital fluorescence microscopy indicate improved tumor microcirculation in highly vascularized melanomas upon short-term anti-VEGFR treatment.
Eichhorn ME; Strieth S; Luedemann S; Kleespies A; Nöth U; Passon A; Brix G; Jauch KW; Bruns CJ; Dellian M
Cancer Biol Ther; 2008 Jul; 7(7):1006-13. PubMed ID: 18398295
[TBL] [Abstract][Full Text] [Related]
3. Two independent mechanisms essential for tumor angiogenesis: inhibition of human melanoma xenograft growth by interfering with either the vascular endothelial growth factor receptor pathway or the Tie-2 pathway.
Siemeister G; Schirner M; Weindel K; Reusch P; Menrad A; Marmé D; Martiny-Baron G
Cancer Res; 1999 Jul; 59(13):3185-91. PubMed ID: 10397264
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor (VEGF) receptors: drugs and new inhibitors.
Musumeci F; Radi M; Brullo C; Schenone S
J Med Chem; 2012 Dec; 55(24):10797-822. PubMed ID: 23098265
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a designed vascular endothelial growth factor receptor antagonist helical peptide with antiangiogenic activity in vivo.
Basile A; Del Gatto A; Diana D; Di Stasi R; Falco A; Festa M; Rosati A; Barbieri A; Franco R; Arra C; Pedone C; Fattorusso R; Turco MC; D'Andrea LD
J Med Chem; 2011 Mar; 54(5):1391-400. PubMed ID: 21280635
[TBL] [Abstract][Full Text] [Related]
6. Blocking angiogenesis and tumorigenesis with GFA-116, a synthetic molecule that inhibits binding of vascular endothelial growth factor to its receptor.
Sun J; Blaskovich MA; Jain RK; Delarue F; Paris D; Brem S; Wotoczek-Obadia M; Lin Q; Coppola D; Choi K; Mullan M; Hamilton AD; Sebti SM
Cancer Res; 2004 May; 64(10):3586-92. PubMed ID: 15150116
[TBL] [Abstract][Full Text] [Related]
7. Antiangiogenic agents: an update on small molecule VEGFR inhibitors.
Schenone S; Bondavalli F; Botta M
Curr Med Chem; 2007; 14(23):2495-516. PubMed ID: 17979703
[TBL] [Abstract][Full Text] [Related]
8. Antiangiogenic agents targeting different angiogenic pathways have opposite effects on tumor hypoxia in R-18 human melanoma xenografts.
Gaustad JV; Simonsen TG; Andersen LMK; Rofstad EK
BMC Cancer; 2017 Jun; 17(1):411. PubMed ID: 28606060
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic knockout of VEGF-R2 and Tie-2 with an intradiabody reduces tumor growth and angiogenesis in vivo.
Jendreyko N; Popkov M; Rader C; Barbas CF
Proc Natl Acad Sci U S A; 2005 Jun; 102(23):8293-8. PubMed ID: 15928093
[TBL] [Abstract][Full Text] [Related]
10. PTK787/ZK222584, an inhibitor of vascular endothelial growth factor receptor tyrosine kinases, decreases glioma growth and vascularization.
Goldbrunner RH; Bendszus M; Wood J; Kiderlen M; Sasaki M; Tonn JC
Neurosurgery; 2004 Aug; 55(2):426-32; discussion 432. PubMed ID: 15271251
[TBL] [Abstract][Full Text] [Related]
11. Phase II study evaluating the efficacy, safety, and pharmacodynamic correlative study of dual antiangiogenic inhibition using bevacizumab in combination with sorafenib in patients with advanced malignant melanoma.
Mahalingam D; Malik L; Beeram M; Rodon J; Sankhala K; Mita A; Benjamin D; Ketchum N; Michalek J; Tolcher A; Wright J; Sarantopoulos J
Cancer Chemother Pharmacol; 2014 Jul; 74(1):77-84. PubMed ID: 24817603
[TBL] [Abstract][Full Text] [Related]
12. [Value of angiogenesis inhibitors in tumor diseases--preclinical data]].
Berdel WE; Panse J
Onkologie; 2005 Oct; 28 Suppl 4():25-8. PubMed ID: 16205102
[No Abstract] [Full Text] [Related]
13. [Tumor angiogenesis: new approaches to cancer therapy].
Marmé D
Onkologie; 2001 Feb; 24 Suppl 1():1-5. PubMed ID: 11441305
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy.
Shinkaruk S; Bayle M; Laïn G; Déléris G
Curr Med Chem Anticancer Agents; 2003 Mar; 3(2):95-117. PubMed ID: 12678905
[TBL] [Abstract][Full Text] [Related]
15. [VEGF-receptor inhibitors for anti-angiogenesis].
Shibuya M
Nihon Yakurigaku Zasshi; 2003 Dec; 122(6):498-503. PubMed ID: 14639004
[TBL] [Abstract][Full Text] [Related]
16. Anti-tumor angiogenesis therapy using soluble receptors: enhanced inhibition of tumor growth when soluble fibroblast growth factor receptor-1 is used with soluble vascular endothelial growth factor receptor.
Ogawa T; Takayama K; Takakura N; Kitano S; Ueno H
Cancer Gene Ther; 2002 Aug; 9(8):633-40. PubMed ID: 12136423
[TBL] [Abstract][Full Text] [Related]
17. mTOR inhibitor RAD001 (everolimus) has antiangiogenic/vascular properties distinct from a VEGFR tyrosine kinase inhibitor.
Lane HA; Wood JM; McSheehy PM; Allegrini PR; Boulay A; Brueggen J; Littlewood-Evans A; Maira SM; Martiny-Baron G; Schnell CR; Sini P; O'Reilly T
Clin Cancer Res; 2009 Mar; 15(5):1612-22. PubMed ID: 19223496
[TBL] [Abstract][Full Text] [Related]
18. AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity.
Traxler P; Allegrini PR; Brandt R; Brueggen J; Cozens R; Fabbro D; Grosios K; Lane HA; McSheehy P; Mestan J; Meyer T; Tang C; Wartmann M; Wood J; Caravatti G
Cancer Res; 2004 Jul; 64(14):4931-41. PubMed ID: 15256466
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor and vascular endothelial growth factor receptor inhibitors as anti-angiogenic agents in cancer therapy.
Veeravagu A; Hsu AR; Cai W; Hou LC; Tse VC; Chen X
Recent Pat Anticancer Drug Discov; 2007 Jan; 2(1):59-71. PubMed ID: 18221053
[TBL] [Abstract][Full Text] [Related]
20. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
Timke C; Zieher H; Roth A; Hauser K; Lipson KE; Weber KJ; Debus J; Abdollahi A; Huber PE
Clin Cancer Res; 2008 Apr; 14(7):2210-9. PubMed ID: 18381963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
